A. Croft

发表

IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes

David C. Wilson, Judy H. Cho, C. Gieger, 2018, Nature Communications.

Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data

Judy H. Cho, John P. Ferguson, G. Wainrib, 2019, Scientific Reports.

Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility

Simon C. Potter, Till F. M. Andlauer, M. Pirinen, 2019, Science.

Serious infections in patients with inflammatory bowel disease receiving anti‐tumor‐necrosis‐factor‐alpha therapy: An Australian and New Zealand experience

J. Andrews, P. Bampton, R. Gearry, 2010, Journal of gastroenterology and hepatology.

Development and evaluation of a risk assessment tool to improve clinical triage accuracy for colonoscopic investigations

M. Appleyard, L. Simms, G. Radford-Smith, 2018, BMC Cancer.

Crohn's disease and smoking: is it ever too late to quit?

J. Andrews, P. Bampton, R. Gearry, 2013, Journal of Crohn's & colitis.

Anti‐tumour necrosis factor‐α treatment for perianal Crohn's disease in Australia

P. Bampton, I. Lawrance, G. Radford-Smith, 2010 .

The Multiple Sclerosis Genomic Map: Role of peripheral immune cells and resident microglia in susceptibility

H. Ullum, H. Hakonarson, M. Pericak-Vance, 2017, bioRxiv.

High density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis

Hailiang Huang, Stephan Ripke, Andre Franke, 2014, Nature Genetics.

Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data

Judy H. Cho, John P. Ferguson, G. Wainrib, 2019, Scientific Reports.

Risk assessment in acute ulcerative colitis

A. Croft, 2019 .

Smoking behaviour modifies IL23r‐associated disease risk in patients with Crohn's disease

T. Merriman, Z. Zhao, G. Montgomery, 2015, Journal of gastroenterology and hepatology.

Surgical outcomes in steroid refractory acute severe ulcerative colitis: the impact of rescue therapy

G. Radford-Smith, A. Croft, G. Radford-Smith, 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Outcomes of salvage therapy for steroid‐refractory acute severe ulcerative colitis: ciclosporin vs. infliximab

G. Radford-Smith, A. Croft, J. Doecke, 2013, Alimentary pharmacology & therapeutics.

Markers of Systemic Inflammation in Acute Attacks of Ulcerative Colitis: What Level of C-reactive Protein Constitutes Severe Colitis?

G. Radford-Smith, A. Croft, A. Lord, 2022, Journal of Crohn's & colitis.

Granulocyte–Macrophage Colony-Stimulating Factor Autoantibodies: A Marker of Aggressive Crohn's Disease

Judy H. Cho, John P. Ferguson, M. Silverberg, 2013, Inflammatory bowel diseases.

Development and evaluation of a risk assessment tool to improve clinical triage accuracy for colonoscopic investigations

M. Appleyard, L. Simms, G. Radford-Smith, 2017, BMC Cancer.

High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis

Judy H. Cho, C. Gieger, H. Hakonarson, 2015 .

Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data

Lisa, Husam, John P. Ferguson, 2023 .

Inter-observer agreement for Crohn's disease sub-phenotypes using the Montreal Classification: How good are we? A multi-centre Australasian study.

J. Andrews, P. Bampton, R. Gearry, 2012, Journal of Crohn's & colitis.